Concord Wealth Partners - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$2,0000.0%280.0%0.00%0.0%
Q2 2021$2,000
-33.3%
280.0%0.00%0.0%
Q1 2021$3,0000.0%280.0%0.00%
-50.0%
Q4 2020$3,000280.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders